Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at William Blair boosted their FY2018 earnings per share (EPS) estimates for Henry Schein in a research note issued on Sunday. William Blair analyst J. Kreger now expects that the company will earn $4.03 per share for the year, up from their previous estimate of $4.01. William Blair also issued estimates for Henry Schein’s FY2019 earnings at $4.46 EPS.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, beating the consensus estimate of $0.86 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The business had revenue of $3.06 billion for the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter in the prior year, the business earned $0.82 earnings per share. Henry Schein’s revenue for the quarter was up 6.4% on a year-over-year basis. TRADEMARK VIOLATION WARNING: This piece was originally reported by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.com-unik.info/2017/11/01/fy2018-earnings-estimate-for-henry-schein-inc-issued-by-william-blair-hsic.html.
Other research analysts have also recently issued research reports about the stock. UBS AG reiterated a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. Northcoast Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price target on the stock in a report on Monday, August 7th. Robert W. Baird set a $95.00 price target on shares of Henry Schein and gave the company a “buy” rating in a report on Thursday, October 19th. Morgan Stanley assumed coverage on shares of Henry Schein in a report on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 price target on the stock. Finally, Stifel Nicolaus restated a “hold” rating and issued a $89.00 target price on shares of Henry Schein in a report on Thursday, October 19th. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and six have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $92.89.
Henry Schein declared that its Board of Directors has approved a share repurchase plan on Monday, September 18th that allows the company to repurchase $400.00 million in outstanding shares. This repurchase authorization allows the company to purchase up to 6.3% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.
In other Henry Schein news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the sale, the senior vice president now directly owns 17,841 shares in the company, valued at $3,077,750.91. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.19% of the stock is currently owned by company insiders.
Institutional investors have recently modified their holdings of the stock. YorkBridge Wealth Partners LLC lifted its stake in Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after acquiring an additional 28 shares during the last quarter. Sun Life Financial INC increased its holdings in shares of Henry Schein by 8,185.7% in the 2nd quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after acquiring an additional 573 shares during the period. Lee Financial Co acquired a new position in shares of Henry Schein in the 2nd quarter valued at $161,000. Acrospire Investment Management LLC increased its holdings in shares of Henry Schein by 150.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock valued at $183,000 after acquiring an additional 600 shares during the period. Finally, HM Payson & Co. acquired a new position in shares of Henry Schein in the 2nd quarter valued at $204,000. Institutional investors own 47.48% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
What are top analysts saying about Henry Schein Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Henry Schein Inc. and related companies.